Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | GLI1 | P08151 | 1/20 | 0.32 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3629197 | 0.86 | EPHX1 (0.36) | EPHX1HRH3KDM4EMAPTKMT2A | |
| SCHEMBL2549796 | 0.83 | LMNA (0.33) | EPHX1KDM4EMAPTKMT2AATM | |
| SCHEMBL15232945 | 0.83 | GLI1 (0.32) | GLI1 | |
| SCHEMBL29950626 | 0.76 | POLB (0.40) | KDM4EMAPTKMT2AGRM2 | |
| SCHEMBL22660589 | 0.76 | POLB (0.40) | KDM4EMAPTKMT2AGRM2 | |
| SCHEMBL24516573 | 0.75 | MEN1 (0.37) | KMT2ACYP2D6 | |
| SCHEMBL3774101 | 0.75 | MEN1 (0.37) | KMT2ACYP2D6 | |
| SCHEMBL8795414 | 0.75 | LMNA (0.44) | KDM4EMAPTKMT2A | |
| SCHEMBL6078824 | 0.75 | MEN1 (0.37) | KMT2ACYP2D6 | |
| SCHEMBL3764733 | 0.75 | MEN1 (0.37) | KMT2ACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695231-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | Tenvie Therapeutics Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| WO-2024216209-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | NICO THERAPEUTICS, INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| CN-103958473-A | Amide compound, composition and application thereof | ADVINUS THERAPEUTICS LTD | 2014-07-30 | — | — | CN | disclosed |